Spyre Therapeutics Quote - SYRE

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

21.40

Bid

20.00

Ask

23.00

Volume

774

0.00 Day's Range 0.00

15.00 52 Week Range 47.97

Market Cap

1.101B

Previous Close

21.79

Open

Last Trade

21.79

Last Trade Time

07:32:43

Financial Volume

VWAP

Average Volume (3m)

617,266

Shares Outstanding

51,431,220

Dividend Yield

PE Ratio

-3.31

Earnings Per Share (EPS)

-6.59

Revenue

886k

Net Profit

-338.79M

Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an e... Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.spyre.com

Headquarters

Wilmington, Delaware, USA

Founded

Spyre Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SYRE. The last closing price for Spyre Therapeutics was US$21.79. Over the last year, Spyre Therapeutics shares have traded in a share price range of US$ 15.00 to US$ 47.97.

Spyre Therapeutics currently has 51,431,220 shares outstanding. The market capitalization of Spyre Therapeutics is US$1.12 billion. Spyre Therapeutics has a price to earnings ratio (PE ratio) of -3.31.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.29	-5.68532393125	22.69	22.81	15	527605	21.53078614	CS
4	-2.2	-9.32203389831	23.6	26.01	15	574851	22.26657752	CS
12	-15.6	-42.1621621622	37	40.26	15	617266	26.4364763	CS
26	-9.65	-31.0789049919	31.05	40.26	15	533072	27.73248952	CS
52	-6.1	-22.1818181818	27.5	47.97	15	524109	29.54780438	CS
156	10.59	97.9648473636	10.81	47.97	10.42	480012	29.05034349	CS
260	10.59	97.9648473636	10.81	47.97	10.42	480012	29.05034349	CS

SYRE - Frequently Asked Questions (FAQ)

What is the current Spyre Therapeutics share price?

The current share price of Spyre Therapeutics is US$ 21.40

How many Spyre Therapeutics shares are in issue?

Spyre Therapeutics has 51,431,220 shares in issue

What is the market cap of Spyre Therapeutics?

The market capitalisation of Spyre Therapeutics is USD 1.12B

What is the 1 year trading range for Spyre Therapeutics share price?

Spyre Therapeutics has traded in the range of US$ 15.00 to US$ 47.97 during the past year

What is the PE ratio of Spyre Therapeutics?

The price to earnings ratio of Spyre Therapeutics is -3.31

What is the cash to sales ratio of Spyre Therapeutics?

The cash to sales ratio of Spyre Therapeutics is 1.27k

What is the reporting currency for Spyre Therapeutics?

Spyre Therapeutics reports financial results in USD

What is the latest annual turnover for Spyre Therapeutics?

The latest annual turnover of Spyre Therapeutics is USD 886k

What is the latest annual profit for Spyre Therapeutics?

The latest annual profit of Spyre Therapeutics is USD -338.79M

What is the registered address of Spyre Therapeutics?

The registered address for Spyre Therapeutics is 1521 CONCORD PIKE, SUITE 201, NEW CASTLE, WILMINGTON, DELAWARE, 19803

What is the Spyre Therapeutics website address?

The website address for Spyre Therapeutics is www.spyre.com

Which industry sector does Spyre Therapeutics operate in?

Spyre Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OCEAOcean Biomedical Inc	US$ 0.64075 (94.17%)	38.93M
NOEMUCO2 Energy Transition Corporation	US$ 16.12 (57.27%)	6
SLXNSilexion Therapeutics Corporation	US$ 2.08 (54.07%)	65.52M
LGCLLucas GC Ltd	US$ 0.7943 (38.86%)	24.06M
EVTVEnvirotech Vehicles Inc	US$ 0.74 (30.05%)	32.77M
TMCITreace Medical Concepts Inc	US$ 5.01 (-47.01%)	11
CPSSConsumer Portfolio Services Inc	US$ 7.01 (-41.24%)	18
RILYTB Riley Financial Inc	US$ 6.00 (-37.66%)	1
AURAAura Biosciences Inc	US$ 5.02 (-36.05%)	1
ZKINZK International Group Co Ltd	US$ 0.565 (-30.99%)	626.64k
SLXNSilexion Therapeutics Corporation	US$ 2.08 (54.07%)	65.52M
OCEAOcean Biomedical Inc	US$ 0.64075 (94.17%)	38.93M
EVTVEnvirotech Vehicles Inc	US$ 0.74 (30.05%)	32.77M
SXTP60 Degrees Pharmaceuticals Inc	US$ 0.966 (25.32%)	32.15M
LGCLLucas GC Ltd	US$ 0.7943 (38.86%)	24.06M